Table 4.
Nutrient source (key nutrient) | Mechanism of action | Suggested benefits | Refs |
---|---|---|---|
BCAAs (Leucine, Valine, Isoleucine) | Increased MPS | ↓DMG, ↓DOMS, ↑MF | [88] |
Creatine | Anti-inflammatory properties | ↓DMG, ↓DOMS, ↓INF, ↑MF | [89, 91–100] |
HMB | Increased MPS and cellular membrane integrity | ↓DMG, ↓DOMS, ↑MF | [101–106] |
L-glutamine | Anti-inflammatory properties | ↓DMG, ↓DOMS, ↑MF | [107–110] |
Protein | Increased MPS | ↓DOMS, ↑MF | [111] |
Taurine | Antioxidant properties | ↓DMG, ↓DOMS, ↑MF | [113–116] |
BCAAs branched-chain amino acids, ↓DMG nutrient reduced indirect markers of muscle damage compared to placebo, ↓DOMS nutrient reduced soreness and delayed-onset muscle soreness compared to placebo, ↓INF nutrient reduced markers of inflammation compared to placebo, HMB β-hydroxy-β-methylbutyrate, ↑MF nutrient improved muscle function relative to placebo